Galderma raises full-year sales outlook again
Swiss skincare company Galderma lifted its full-year sales guidance for the second consecutive quarter after posting robust nine-month net sales driven by its therapeutic dermatology division.
Xurve View
Insights:
Xurve View
GALDERMA GROUP AG raised its full-year sales guidance to 22.5-23.5% after posting $4.77 billion in net sales through the first nine months. The Switzerland-based skincare company lifted its outlook for the second consecutive quarter following robust demand. The upward revision highlights accelerating momentum across the firm's core therapeutic dermatology portfolio.
